PGNY News and Press, Progyny Inc. From 10/20/21

The percentage of companies in the US that cover fertility benefits has grown significantly over the past five years. Progyny specializes in fertility benefits management and in a span of 5 years since launch has seen covered lives grow 25x, and employer clients expand from 5 to 180+....

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Li...

Healthcare had a slow start but now is one of the leading sectors in terms of 2021 performance. Healthcare is well-positioned to benefit from growing spending and pent-up demand. The sector is also a defensive investment if economic growth concerns mount. Regulatory risk remai...

Investors love the explosive growth that many healthcare stocks can provide. But it's hard to find many that offer growth and profits like Progyny (NASDAQ: PGNY) does. In this video from Motley Fool Live , recorded on Aug. 26 , Fool contributor Brian Feroldi explains not...

Castlight Health Expands Ecosystem with Four New Digital Health Partners Additions enable healthcare navigation leader to continue addressing increasingly complex workplace health challenges PR Newswire SAN FRANCISCO , Aug. 24, 2021 /PRNewswire/ -- Castlig...

New York, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced a pregnancy loss leave benefit for all employees effective immediately. The&#...

Progyny, Inc. (PGNY) Q2 2021 Earnings Conference Call August 05, 2021 4:45 PM ET Company Participants James Hart – Vice President-Investor Relations David Schlanger – Chief Executive Officer Pete Anevski – President and Chief Operating Officer Mark Livingston – Chi...

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will partici...

Progyny (NASDAQ:PGNY): Q2 GAAP EPS of $0.19 beats by $0.12. Revenue of $128.65M (+99.1% Y/Y) misses by $0.64M. Press Release For further details see: Progyny EPS beats by $0.12, misses on revenue

Reports Record Second Quarter Revenue of $128.7 Million, Reflecting 99% Growth Achieving Record Sales Momentum – Demand Among Prospective Accounts Returns to Pre-COVID Levels NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management...